8th ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology

Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs: J. Gligorov, FR - S. Khatib, JO
Host Chair: D. Papamichael, CY


AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, gynaecological, lung, urological and gastrointestinal cancers. Spotlight sessions will facilitate compact update on head and neck, melanoma, elderly patients, soft tissue sarcoma, non-Hodgkin lymphoma cancer of unknown primary, supportive care and the role of informal supporter.

TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

THE MASTERCLASS IS:
• Full immersion
• 3-and-a-half-day residential event
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast, gynaecological, lung, urological and gastrointestinal cancers.

Held under the auspices of the

 
In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

• Download PDF document

FACULTY
M.S. Aapro, Clinique de Genolier, CH
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Azim jr, American University of Beirut, LB
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
S. Cascinu, Università di Modena e Reggio Emilia, Modena, IT
G. Ceresoli, Humanitas Gavazzeni, Bergamo, IT
A. Charalambous, Cyprus University of Technology, Limassol, CY
A. Constantinidou, University of Cyprus, Medical School, Nicosia, CY
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
F. Geara, American University of Beirut, LB
H. Gogas, University of Athens, Athens, GR
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
P. Kountourakis, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, Ioannina School of Medicine, GR
G. Pruneri, European Institute of Oncology, Milan, IT
J. Remon-Masip, Centro Integral Oncología Clara Campal (CIOCC), Barcelona, ES
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Temraz, American University of Beirut, LB
J.B. Vermorken, Antwerp University Hospital, BE

ORGANISING SECRETARIAT
European School of Oncology
Dolores Knupfer
Piazza Indipendenza 2
6500 Bellinzona
Switzerland
Ph +41 91 820 0951 or 52, Fx +41 91 820 0953
Email: dknupfer@eso.net

Applications:
Alice Ciocchini, aciocchini@eso.net, ph +39 02 85464529

TRAVEL SUPPORT
Travel support will be made available as a contribution to travel expenses, to admitted participants coming from lower-middle- income countries as defined by the World Bank.

CERTIFICATE OF ATTENDANCE
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
The programme is furthermore accredited with 25 ESMO-MORA category 1 points.

IDEAL MASTERCLASS CANDIDATE
• Age below 40 years
• At least 2-3 years’ experience in medical or clinical oncology
• Involvement in scientific activities (preferable)
• Intermediate level of English

Priority will be given to suitable applicants working in Arab and Southern European countries.

Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event-dedicated website will be created and all questionnaires and certificates will be accessible only from there.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
Successful applicants are granted free registration and accommodation
THE APPLICATION DEADLINE HAS PASSED (30 JUNE 2019)

23 January

24 January

25 January

26 January

27 January